Sourcebio International (LON:SBI) Stock Price Up 4.5% – Time to Buy?

Sourcebio International Plc (LON:SBI)’s share price traded up 4.5% on Tuesday . The company traded as high as GBX 125 ($1.63) and last traded at GBX 115 ($1.50). 1,571,282 shares were traded during trading, an increase of 931% from the average session volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.43).

Sourcebio International Price Performance

The company has a market capitalization of £85.31 million and a price-to-earnings ratio of 1,277.78. The business has a 50-day moving average price of GBX 115 and a two-hundred day moving average price of GBX 115. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 35.10.

Sourcebio International Company Profile

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.